The value of Spin-outs by Martin Bonde, Chairman Dansk Biotek and Copenhagen Spin-outs

Copenhagen Spin-outs See all

Copenhagen Spin-outs
The value of Spin-outs by Martin Bonde, Chairman Dansk Biotek and Copenhagen Spin-outs

What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.

Tagged with IPR, biotech, biotek, capital, creation, danish, dansk, job, region, research, talents, technology transfer

Copenhagen Spin-outs See all

Marianne Thellersen on...

COLLABORATION BETWEEN RESEARCH, INDUSTRY AND...

Read more
Director Kim Høgh on...

COLLABORATION BETWEEN RESEARCH, INDUSTRY AND...

Read more
Prorector Thomas Bjørnholm...

COLLABORATION BETWEEN RESEARCH, INDUSTRY AND...

Read more
Copenhagen Spin-outs by...
Copenhagen Spin-outs by Gert Balling. Introduction. Short Version.
Copenhagen Spin-outs - Gert...
Copenhagen Spin-outs - Gert Balling. Introduction. Long Version.
Interview with Jeff...

Jeff Skinner, Executive Director, Deloitte Institute of Innovation...

Read more